| A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides A Wolska, L Lo, DO Sviridov, M Pourmousa, M Pryor, SS Ghosh, R Kakkar, ... Science translational medicine 12 (528), eaaw7905, 2020 | 67 | 2020 |
| Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity JA Levine, JM Han, A Wolska, SR Wilson, TP Patel, AT Remaley, ... Journal of clinical lipidology 14 (5), 667-674, 2020 | 19 | 2020 |
| Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach M Reimund, A Wolska, R Risti, S Wilson, D Sviridov, AT Remaley, ... Biochemical and Biophysical Research Communications 519 (1), 67-72, 2019 | 17 | 2019 |
| A new phenotypic classification system for dyslipidemias based on the standard lipid panel M Sampson, RA Ballout, D Soffer, A Wolska, S Wilson, J Meeusen, ... Lipids in health and disease 20, 1-21, 2021 | 14 | 2021 |
| Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial AP Demidowich, A Wolska, SR Wilson, JA Levine, AV Sorokin, SM Brady, ... Journal of clinical lipidology 13 (6), 1016-1022. e2, 2019 | 12 | 2019 |
| The Ploidy State as a Determinant of Hepatocyte Proliferation SR Wilson, AW Duncan Seminars in liver disease 43 (04), 460-471, 2023 | 3 | 2023 |
| Dysregulation of lipid and glucose homeostasis in hepatocyte-specific SLC25A34 knockout mice N Roy, F Alencastro, BA Roseman, SR Wilson, ER Delgado, MC May, ... The American Journal of Pathology 192 (9), 1259-1281, 2022 | 2 | 2022 |
| Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease AV Sorokin, CG Hong, AM Aponte, EM Florida, J Tang, N Patel, ... JCI insight 8 (20), 2023 | 1 | 2023 |
| Single-cell DNA sequencing reveals chromosomal diversity in HCC and a novel model of HCC evolution SR Wilson, AW Duncan Gastroenterology 162 (1), 46-48, 2022 | 1 | 2022 |
| A dual ApoC-II mimetic-ApoC-III antagonist peptide as a potential treatment for hypertriglyceridemia A Wolska, D Sviridov, M Pourmousa, R Pastor, M Pryor, S Wilson, L Lo, ... Atherosclerosis 331, e123-e124, 2021 | | 2021 |
| A Dual apoC-II mimetic-apoC-III Antagonist Peptide for Lowering Plasma Triglycerides A Wolska, L Lo, DO Sviridov, M Pourmousa, M Pryor, SS Ghosh, R Kakkar, ... Arteriosclerosis, Thrombosis, and Vascular Biology 39 (Suppl_1), A690-A690, 2019 | | 2019 |
